Allspring Global Investments
PCVX icon

Allspring Global Investments’s Vaxcyte PCVX Stock Holding History

Allspring Global Investments’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$413K Buy
7,364
+895
+14% +$48.6K ﹤0.01% 1496
2026
Q1 		$378K Buy
6,469
+619
+11% +$33.6K ﹤0.01% 1470
2025
Q4 		$272K Buy
+5,850
New +$262K ﹤0.01% 1532
2025
Q3 		– Sell
-8,425
Closed -$278K – 1708
2025
Q2 		$278K Sell
8,425
-327,565
-97% -$10.7M ﹤0.01% 1489
2025
Q1 		$10.8M Sell
335,990
-257,533
-43% -$20.6M 0.02% 695
2024
Q4 		$49.4M Buy
593,523
+246,049
+71% +$24.4M 0.08% 300
2024
Q3 		$39.7M Buy
347,474
+3,922
+1% +$353K 0.06% 366
2024
Q2 		$25.9M Buy
343,552
+296,164
+625% +$20.2M 0.04% 485
2024
Q1 		$3.24M Buy
47,388
+24,785
+110% +$1.72M 0.01% 1062
2023
Q4 		$1.42M Buy
22,603
+20,558
+1,005% +$1.07M ﹤0.01% 1253
2023
Q3 		$104K Sell
2,045
-30
-1% -$1.48K ﹤0.01% 1988
2023
Q2 		$104K Sell
2,075
-1,394
-40% -$66.1K ﹤0.01% 2039
2023
Q1 		$130K Sell
3,469
-796
-19% -$33.8K ﹤0.01% 1948
2022
Q4 		$205K Sell
4,265
-94
-2% -$3.69K ﹤0.01% 1817
2022
Q3 		$104K Buy
4,359
+3,198
+275% +$81.1K ﹤0.01% 2072
2022
Q2 		$25K Hold
1,161
– – ﹤0.01% 2433
2022
Q1 		$28K Buy
+1,161
New +$25.4K ﹤0.01% 2914

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Allspring Global Investments's PCVX Position: Q2 2026 in Review

Allspring Global Investments increased its Vaxcyte (PCVX) stake by 14% in Q2 2026, buying an estimated $48.6K and bringing the position to 7,364 shares worth $413K. The position accounts for ﹤0.01% of the portfolio, ranked #1496.

Allspring Global Investments first reported a position in PCVX in Q1 2022 and has held it in 17 quarters since. The position peaked at $49.4M in Q4 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Allspring Global Investments held 7,364 shares of Vaxcyte worth $413K as of Q2 2026.
  • Allspring Global Investments bought 895 Vaxcyte shares in Q2 2026, an estimated $48.6K.
  • Vaxcyte made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1496 holding.
  • Allspring Global Investments first reported a position in Vaxcyte in Q1 2022 and has held it in 17 quarters since.
  • Allspring Global Investments's Vaxcyte position peaked at $49.4M in Q4 2024.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.